Therefore, combining the other three known risk factors in the Mayo 2012 staging system (cTnI, NT-proBNP, dFLC) with sST2 at a value of 12.34 ng/ml, a new scoring system was established for predicting the OS of AL amyloidosis patients as reported previously (6). This evidence concerns the gene NPPB and AL amyloidosis.